Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Auspex Pharmaceuticals Company Profile (NASDAQ:ASPX)

Consensus Ratings for Auspex Pharmaceuticals (NASDAQ:ASPX) (?)
Ratings Breakdown: 7 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $55.33 (3.68% upside)

Analysts' Ratings History for Auspex Pharmaceuticals (NASDAQ:ASPX)
Show:
DateFirmActionRatingPrice TargetDetailsShare
12/17/2014ZacksReiterated RatingOutperform -> Outperform$60.00ViewTweet This Rating  Share This Rating on StockTwits
12/17/2014BMO Capital MarketsBoost Price TargetOutperform$40.00 -> $60.00ViewTweet This Rating  Share This Rating on StockTwits
12/17/2014Stifel NicolausBoost Price TargetBuy$40.00 -> $61.00ViewTweet This Rating  Share This Rating on StockTwits
12/17/2014Piper JaffrayBoost Price Target$72.00ViewTweet This Rating  Share This Rating on StockTwits
10/30/2014Piper JaffrayInitiated CoverageOverweight$50.00ViewTweet This Rating  Share This Rating on StockTwits
9/25/2014Ladenburg ThalmannInitiated CoverageBuy$37.00ViewTweet This Rating  Share This Rating on StockTwits
8/8/2014Stifel NicolausBoost Price TargetBuy$39.00 -> $40.00ViewTweet This Rating  Share This Rating on StockTwits
7/11/2014Robert W. BairdBoost Price TargetOutperform$34.00 -> $42.00ViewTweet This Rating  Share This Rating on StockTwits
3/28/2014Stifel NicolausBoost Price Target$38.00 -> $39.00ViewTweet This Rating  Share This Rating on StockTwits
3/3/2014William BlairInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
3/3/2014Stifel NicolausInitiated CoverageBuy$38.00ViewTweet This Rating  Share This Rating on StockTwits
3/3/2014Robert W. BairdInitiated CoverageOutperform$34.00ViewTweet This Rating  Share This Rating on StockTwits
3/3/2014BMO Capital MarketsInitiated CoverageOutperform$39.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 12/21/2012 forward)